SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 21,580 shares at $9.54 ($206K) on 2017-12-27, disclosed to the SEC on 2017-12-28.
Open-market sale of $206k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.59 | 4,798 | $46K | 22.3% |
| 2 | $9.54 | 8,391 | $80K | 38.8% |
| 3 | $9.54 | 8,391 | $80K | 38.8% |
| Total | $9.55 avg | 21,580 | $206K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-04 | $689K | — | Filing → |
| REPH | SELL | 2018-01-02 | $338K | — | Filing → |